Santé
IPC-3D
An R&D platform at the leading edge of leukaemia treatment
Partnership Carnot OPALE Institute - Imcheck Therapeutics Entreprise
Presentation
Video
Fermer
Within Carnot OPALE institute, the IPC-Drug Discovery and Development programme (IPC-3D) offers a unique platform catering to the needs of players in the biopharmaceutical sector. IPC-3D is focused exclusively on the key issues involved in their pipeline development, from identification of new therapeutic targets through early evaluation of drug candidates in humans.
